Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.
about
Venous thromboembolic diseaseHeparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsCurrent concepts review: heparin-induced thrombocytopenia.A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals.Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia.The utility of pre-test clinical scoring for clinical diagnosis of heparin-induced thrombocytopenia in cardiac surgery patients of a tertiary care centre in north India.Assessment of the 4Ts pretest clinical scoring system as a predictor of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: present and future.Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.The impact of the heparin-induced thrombocytopenia (HIT) computerized alert on provider behaviors and patient outcomesRapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.Anticoagulants: therapeutics, risks, and toxicity--special emphasis on heparin-induced thrombocytopenia (HIT).Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.Contributions of biological tests and the 4 Ts score in the diagnosis of heparin induced thrombocytopenia.Novel diagnostic assays for heparin-induced thrombocytopeniaRapid diagnosis of heparin-induced thrombocytopenia using a particle gel immunoassay in at-risk cardiac surgery patients.Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.An algorithm for the identification of heparin-induced thrombocytopenia using a medical information database.Platelet factor 4/heparin-particle gel immunoassay (PaGIA) is a weak method for heparin-induced thrombocytopenia (HIT) evaluation of post cardio-pulmonary bypass surgery patients.Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failureCurrent insights into the laboratory diagnosis of HIT.Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia.Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia.Over-testing for heparin induced thrombocytopenia in hospitalized patients.Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring systemAn update on heparin-induced thrombocytopenia: diagnosis and management.How we manage patients with heparin induced thrombocytopenia.Heparin-induced thrombocytopenia: reducing misdiagnosis via collaboration between an inpatient anticoagulation pharmacy service and hospital reference laboratory.Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program.Fondaparinux Treatment in a Neonate with Heparin Induced Thrombocytopenia during Extracorporeal Life Support.Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.False positive immunoassay for heparin-induced thrombocytopenia in the presence of monoclonal gammopathy: a case report.Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.Clinical Significance of the Serotonin Release Assay and Platelet Count Monitoring After Cardiac Surgery.Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?
P2860
Q24631121-1C1B7100-DD0C-43BD-BB11-5E911F54629EQ26799395-51A4F2DB-C967-4AA6-9DC7-DF3D4DE77E45Q33382108-96455193-5125-4218-AEB2-48DD003B57C0Q33385881-017E2317-A8BF-442A-A3E0-B72786253DE6Q33389558-2A79AD92-5E0D-402F-A930-F2A08DA0CF64Q33393837-499C1FA4-F90C-4422-86E0-D59B566D6B84Q33393894-9D73D69B-EBA9-4EAB-9AB2-95C7404664FFQ33394188-0CFE636A-7081-4F4A-AFF9-17D8AA060743Q33394199-A897988D-CA72-43D1-AC3B-A444D58A3194Q33395976-12CB8ED2-08C2-4686-BF4E-60E8BB49A5C6Q33397294-F3D36BE2-975E-4F99-AB7A-BB1E20F005C8Q33399119-19FFC908-5DBE-4DB6-A5B6-AA3BBF4D55AEQ33399580-E10A4051-BA29-4D25-9B9F-4D68B1689AC0Q33400008-F482D45C-DF9F-405B-BDFB-DA84038DCC98Q33400685-DA1141E7-4DBB-4BA0-9124-741EA9F52EB7Q33403113-CDDEFDDF-E602-4F6B-A77C-1532A5FAF80EQ33403395-F53E3018-9821-42C1-8810-288110F94BB7Q33403703-4F18020A-82E7-4FA3-A820-C30CB76833D0Q33405248-2888A8A7-429E-4C54-88DA-28EF7C8ECFB2Q33406133-862403C3-3FC1-4125-9860-B2B529AF2240Q33406881-548C3C27-7ECB-4866-8038-8920DF0476AFQ33408778-7D37E1EA-0DA2-4EC1-A250-C56FAD7C933AQ33409039-242D41F8-6AF0-4BEA-AB8A-C5788C4A07C5Q33413476-1940B87E-1B52-403A-A974-647E8D2ECEA6Q33414539-093DA694-C8AF-4627-AFE7-AD99A05AD913Q33414746-AE9046D7-4834-4CC1-98D5-6450315919AAQ33415202-9F64B3D7-E8B0-4794-94F2-34E454550788Q33416580-4BA2FF12-D1A6-4B34-B51E-7C0EBB453513Q33417093-56C601DF-4A75-4684-A95C-566E08A5C590Q33418994-F67296C3-6E1F-4D87-9EE1-799DBD215329Q33430644-55FE3A70-A6F7-42ED-9773-E23B99A09EA7Q33431626-9F68E067-923E-493D-9385-B77F525340E4Q33432521-92AF8C73-9E65-4D62-91F2-319082A0955AQ33434438-20226045-7647-4194-9F6D-A3AAA62B4AAEQ33441549-25A5B0C2-C66C-42F0-89F0-3B7B3391099FQ33442746-3F849C4E-E1B1-44AC-BC78-42C4A496C510Q47133217-C4EC6400-FC08-4E97-B6C9-5793E529B407Q47630566-CA3B97B1-48A6-4F85-8A2A-C4C7D3942F20Q50090659-F0998406-CBEF-43ED-98CA-4CF7C171D1C8Q53085054-FDEC0FDA-279F-4458-B072-E6A882640F8B
P2860
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prospective evaluation of the ...... arin-induced thrombocytopenia.
@ast
Prospective evaluation of the ...... arin-induced thrombocytopenia.
@en
type
label
Prospective evaluation of the ...... arin-induced thrombocytopenia.
@ast
Prospective evaluation of the ...... arin-induced thrombocytopenia.
@en
prefLabel
Prospective evaluation of the ...... arin-induced thrombocytopenia.
@ast
Prospective evaluation of the ...... arin-induced thrombocytopenia.
@en
P2093
P2860
P1476
Prospective evaluation of the ...... arin-induced thrombocytopenia.
@en
P2093
Fouassier M
Pouplard C
Ternisien C
Trossaert M
P2860
P304
P356
10.1111/J.1538-7836.2007.02524.X
P577
2007-03-14T00:00:00Z